ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sound Pharma Advances Pivotal Phase 3 Clinical Trials in Meniere's Disease
June 17, 2020Sound Pharmaceuticals announced the FDA has allowed its pivotal Phase 3 clinical protocol for SPI-1005 in the Treatment of Patients with Meniere's Disease (STOPMD-3). -
University of Oxford, Sound Pharmaceuticals Complete Phase 2 Bipolar Disorder Study
May 11, 2020The University of Oxford and Sound Pharmaceuticals (SPI) announced the successful completion of a Phase 2a study testing SPI-1005 as a new treatment for bipolar disorder (BPD). -
Sound Pharmaceuticals Announces Positive Topline Results from SPI-1005 Phase 2b Trial
June 26, 2019Sound Pharmaceuticals announced positive top-line results from a randomized, double-blind, placebo-controlled, multi-center Phase 2b study in Meniere's Disease (MD).
Pharma Sources Insight January 2025
